Skip to main content
Meet Van, a patient with PSMA+ mCRPC

Sometimes it helps to know what the PLUVICTO process was like for other patients.* Watch Van talk about his PLUVICTO journey.

*Patient experiences are individual and vary. 

See what's behind the making of PLUVICTO

A lot goes into PLUVICTO before it gets to you. The manufacturing process is the ultimate race against the clock. Take a peek at this behind-the-scenes video about the making of PLUVICTO, and you'll understand why Novartis is committed to discovering and developing treatments like PLUVICTO for patients like you.

Understanding treatment with PLUVICTO

Knowing what to expect in your treatment with PLUVICTO may help you and your family be prepared and empowered to ask your doctor any questions you may have. For a written overview about the experience with each step of the PLUVICTO process, go to What to Expect When Taking PLUVICTO.

Important Safety Information

What is the most important information I should know about PLUVICTO?

Use of PLUVICTO involves exposure to radioactivity. Long-term, accruing radiation exposure is associated with an increased risk for cancer...

Approved Use

What is PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)?

PLUVICTO is a radiopharmaceutical used to treat adults with an advanced cancer called prostate-specific membrane antigen­–­positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that...